<DOC>
	<DOC>NCT00556426</DOC>
	<brief_summary>This study was designed to assess the safety of retrieval of the Bard Recovery® G2® Filter System. The G2 filter is an FDA-cleared device for inferior vena caval interruption in patients with pulmonary thromboembolism.</brief_summary>
	<brief_title>Prospective, Multi-center, Single-arm Study to Assess the Safety of Retrieval of the Recovery G2 Filter.</brief_title>
	<detailed_description />
	<mesh_term>Embolism</mesh_term>
	<mesh_term>Pulmonary Embolism</mesh_term>
	<mesh_term>Thromboembolism</mesh_term>
	<criteria>The patient is at temporary , increased risk of pulmonary embolism requiring caval interruption The patient has implanted filter in the IVC or superior vena cava (SVC) The patient has a duplicated or leftsided IVC The patient has a known untreatable or uncontrollable malignancy The patient has severe spinal deformity The patient has a creatinine &gt; 2.0 mg/dl The patient has a life expectancy of &lt; 6 months</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Venous Thromboembolic Disease</keyword>
	<keyword>IVC Filter</keyword>
	<keyword>Pulmonary Embolism</keyword>
</DOC>